Powell Andrew Kenneth William 4
4 · Silverback Therapeutics, Inc. · Filed Sep 21, 2021
Insider Transaction Report
Form 4
Powell Andrew Kenneth William
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-04+15,000→ 15,000 totalExercise: $28.83Exp: 2031-06-03→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest on the earlier of June 4, 2022 or the date of the 2022 annual meeting of the Issuer's stockholders which date has not been set by the Issuer's Board of Directors.